FibroGen
FGEN
$1.04
Share price
1.96%
Change (1 day)
-93.93%
Change (1 year)
Categories
FibroGen (FGEN) - Total assets
Total assets on the balance sheet as of December 2023 : $0.42 B
According to FibroGen's latest financial reports the company's total assets are $0.42 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
FibroGen - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.42 B | -30.58% |
| 2022-12-31 | $0.61 B | -21.16% |
| 2021-12-31 | $0.77 B | -6.41% |
| 2020-12-31 | $0.82 B | -3.56% |
| 2019-12-31 | $0.85 B | -2.63% |
| 2018-12-31 | $0.88 B | -2.01% |
| 2017-12-31 | $0.89 B | 91.38% |
| 2016-12-31 | $0.46 B | -0.22% |
| 2015-12-31 | $0.47 B | -2.68% |
| 2014-12-31 | $0.48 B | 62.83% |
| 2013-12-31 | $0.29 B | 11.81% |
| 2012-12-31 | $0.26 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | $10.11 B | 2,287.32% | 🇺🇸 USA |
 Acceleron Pharma XLRN | N/A | N/A | 🇺🇸 USA |
 Accelerate Diagnostics AXDX | $31.36 M | -92.59% | 🇺🇸 USA |